ProtoKinetix, Incorporated (PKTX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 30, 2026, 4:00 PM EST
ProtoKinetix Market Cap
ProtoKinetix has a market cap or net worth of $2.26 million as of July 31, 2026. Its market cap has increased by 7.75% in one year.
Market Cap
2.26M
Enterprise Value
2.26M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since January 7, 2002, ProtoKinetix's market cap has increased from 60.38K to 2.26M, an increase of 3,649.84%. That is a compound annual growth rate of 15.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.26M | -7.02% |
| Dec 31, 2025 | 2.43M | -34.52% |
| Dec 31, 2024 | 3.72M | -43.47% |
| Dec 29, 2023 | 6.58M | -22.09% |
| Dec 30, 2022 | 8.44M | -71.61% |
| Dec 31, 2021 | 29.74M | 5.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Affymax | 74.49K |
| Ocean Biomedical | 69.71K |
| Vincerx Pharma | 66.48K |
| Sigyn Therapeutics | 63.57K |
| PaxMedica | 63.14K |
| Panbela Therapeutics | 53.89K |
| Vaxxinity | 25.35K |
| Nanobac Pharmaceuticals | 24.95K |